334 related articles for article (PubMed ID: 17003175)
1. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders.
Wolfe F; Michaud K; Chakravarty EF
Rheumatology (Oxford); 2006 Nov; 45(11):1370-5. PubMed ID: 17003175
[TBL] [Abstract][Full Text] [Related]
2. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.
Wolfe F; Caplan L; Michaud K
Arthritis Rheum; 2006 Feb; 54(2):628-34. PubMed ID: 16447241
[TBL] [Abstract][Full Text] [Related]
3. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.
Chakravarty EF; Michaud K; Wolfe F
J Rheumatol; 2005 Nov; 32(11):2130-5. PubMed ID: 16265690
[TBL] [Abstract][Full Text] [Related]
4. Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.
Pappas DA; Hooper MM; Kremer JM; Reed G; Shan Y; Wenkert D; Greenberg JD; Curtis JR
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1671-8. PubMed ID: 26018115
[TBL] [Abstract][Full Text] [Related]
5. Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate.
Wolfe F; Michaud K; Stephenson B; Doyle J
J Rheumatol; 2003 Aug; 30(8):1725-32. PubMed ID: 12913927
[TBL] [Abstract][Full Text] [Related]
6. The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: a prospective 13 year study of 2131 patients.
Wolfe F; Hawley DJ
J Rheumatol; 2000 Jul; 27(7):1668-73. PubMed ID: 10914849
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors.
Segan J; Staples MP; March L; Lassere M; Chakravarty EF; Buchbinder R
Intern Med J; 2015 Mar; 45(3):310-8. PubMed ID: 25565419
[TBL] [Abstract][Full Text] [Related]
9. Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids. A population-based cohort study.
Sihvonen S; Korpela M; Mustonen J; Huhtala H; Karstila K; Pasternack A
J Rheumatol; 2006 Sep; 33(9):1740-6. PubMed ID: 16881099
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of herpes zoster among patients with systemic lupus erythematosus.
Chakravarty EF; Michaud K; Katz R; Wolfe F
Lupus; 2013 Mar; 22(3):238-44. PubMed ID: 23257402
[TBL] [Abstract][Full Text] [Related]
11. Performance of a rheumatoid arthritis records-based index of severity.
Ting G; Schneeweiss S; Katz JN; Weinblatt ME; Cabral D; Scranton RE; Solomon DH
J Rheumatol; 2005 Sep; 32(9):1679-87. PubMed ID: 16142860
[TBL] [Abstract][Full Text] [Related]
12. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.
Nicola PJ; Maradit-Kremers H; Roger VL; Jacobsen SJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2005 Feb; 52(2):412-20. PubMed ID: 15692992
[TBL] [Abstract][Full Text] [Related]
13. Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions.
Yuen SY; Rochwerg B; Ouimet J; Pope JE
J Rheumatol; 2008 Jun; 35(6):1073-8. PubMed ID: 18412305
[TBL] [Abstract][Full Text] [Related]
14. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia.
Liao TL; Chen YM; Liu HJ; Chen DY
BMJ Open; 2017 Jan; 7(1):e014032. PubMed ID: 28057661
[TBL] [Abstract][Full Text] [Related]
15. Predictors of infection in rheumatoid arthritis.
Doran MF; Crowson CS; Pond GR; O'Fallon WM; Gabriel SE
Arthritis Rheum; 2002 Sep; 46(9):2294-300. PubMed ID: 12355476
[TBL] [Abstract][Full Text] [Related]
16. Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout.
de Klerk E; van der Heijde D; Landewé R; van der Tempel H; Urquhart J; van der Linden S
J Rheumatol; 2003 Jan; 30(1):44-54. PubMed ID: 12508389
[TBL] [Abstract][Full Text] [Related]
17. The association of rheumatoid arthritis and its treatment with sinus disease.
Michaud K; Wolfe F
J Rheumatol; 2006 Dec; 33(12):2412-5. PubMed ID: 17143978
[TBL] [Abstract][Full Text] [Related]
18. Incidence of clinically important 10-year health status and disease activity levels in population-based cohorts with rheumatoid arthritis.
Odegård S; Kvien TK; Uhlig T
J Rheumatol; 2008 Jan; 35(1):54-60. PubMed ID: 18050381
[TBL] [Abstract][Full Text] [Related]
19. Rheumatoid arthritis treatment and the risk of severe interstitial lung disease.
Wolfe F; Caplan L; Michaud K
Scand J Rheumatol; 2007; 36(3):172-8. PubMed ID: 17657669
[TBL] [Abstract][Full Text] [Related]
20. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]